The investment seeks long-term capital appreciation... Show more
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Category ForeignLargeGrowth
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| DMCFX | 30.89 | 0.28 | +0.91% |
| Invesco Discovery Mid Cap Growth R5 | |||
| RAGTX | 78.83 | 0.66 | +0.84% |
| Virtus Zevenbergen Technology A | |||
| DRDIX | 25.65 | 0.13 | +0.51% |
| Dearborn Partners Rising Dividend I | |||
| WHGQX | 14.25 | 0.07 | +0.49% |
| Westwood Quality Value Ultra | |||
| SBHIX | 27.30 | -0.10 | -0.36% |
| Saratoga Health & Biotechnology I | |||
A.I.dvisor indicates that over the last year, MGFRX has been closely correlated with CNPAX. These tickers have moved in lockstep 76% of the time. This A.I.-generated data suggests there is a high statistical probability that if MGFRX jumps, then CNPAX could also see price increases.
| Ticker / NAME | Correlation To MGFRX | 1D Price Change % | ||
|---|---|---|---|---|
| MGFRX | 100% | +0.39% | ||
| CNPAX - MGFRX | 76% Closely correlated | +0.47% | ||
| CNPFX - MGFRX | 76% Closely correlated | +0.47% | ||
| CNPEX - MGFRX | 76% Closely correlated | +0.47% | ||
| RPEBX - MGFRX | 75% Closely correlated | +0.46% | ||
| FFPNX - MGFRX | 74% Closely correlated | +0.47% | ||
More | ||||